A detailed history of Hamel Associates, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Hamel Associates, Inc. holds 16,994 shares of AMGN stock, worth $4.48 Million. This represents 1.69% of its overall portfolio holdings.

Number of Shares
16,994
Previous 17,095 0.59%
Holding current value
$4.48 Million
Previous $5.34 Million 2.51%
% of portfolio
1.69%
Previous 1.7%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$309.38 - $337.38 $31,247 - $34,075
-101 Reduced 0.59%
16,994 $5.48 Million
Q2 2024

Aug 02, 2024

SELL
$262.75 - $319.31 $788 - $957
-3 Reduced 0.02%
17,095 $5.34 Million
Q4 2023

Feb 08, 2024

BUY
$255.7 - $288.46 $93,330 - $105,287
365 Added 2.18%
17,098 $4.92 Million
Q3 2023

Nov 03, 2023

BUY
$218.65 - $271.46 $47,009 - $58,363
215 Added 1.3%
16,733 $4.5 Million
Q2 2023

Aug 08, 2023

BUY
$214.27 - $253.37 $645,381 - $763,150
3,012 Added 22.3%
16,518 $3.67 Million
Q1 2023

May 08, 2023

BUY
$225.79 - $275.2 $29,804 - $36,326
132 Added 0.99%
13,506 $3.27 Million
Q3 2022

Nov 09, 2022

SELL
$224.46 - $253.15 $39,280 - $44,301
-175 Reduced 1.29%
13,374 $3.01 Million
Q2 2022

Aug 08, 2022

SELL
$230.71 - $256.74 $13,842 - $15,404
-60 Reduced 0.44%
13,549 $3.3 Million
Q1 2022

May 06, 2022

BUY
$219.27 - $242.57 $107,223 - $118,616
489 Added 3.73%
13,609 $3.29 Million
Q4 2021

Feb 08, 2022

BUY
$198.88 - $227.6 $412,676 - $472,270
2,075 Added 18.79%
13,120 $2.95 Million
Q3 2021

Nov 08, 2021

BUY
$212.27 - $248.7 $203,779 - $238,752
960 Added 9.52%
11,045 $2.35 Million
Q2 2021

Aug 04, 2021

SELL
$233.58 - $259.14 $58,395 - $64,785
-250 Reduced 2.42%
10,085 $2.46 Million
Q1 2021

May 04, 2021

BUY
$221.91 - $258.6 $124,269 - $144,816
560 Added 5.73%
10,335 $2.57 Million
Q4 2020

Feb 11, 2021

SELL
$216.38 - $257.67 $5,409 - $6,441
-25 Reduced 0.26%
9,775 $2.25 Million
Q1 2020

May 07, 2020

BUY
$182.24 - $241.7 $59,228 - $78,552
325 Added 3.43%
9,800 $1.99 Million
Q2 2019

Aug 05, 2019

BUY
$166.7 - $195.41 $383,410 - $449,443
2,300 Added 32.06%
9,475 $1.75 Million
Q1 2019

May 01, 2019

BUY
$180.87 - $203.88 $533,566 - $601,446
2,950 Added 69.82%
7,175 $1.36 Million
Q4 2018

Feb 08, 2019

BUY
$178.4 - $208.25 $8,920 - $10,412
50 Added 1.2%
4,225 $822,000
Q2 2018

Aug 10, 2018

SELL
$166.05 - $186.51 $20,756 - $23,313
-125 Reduced 2.91%
4,175 $771,000
Q2 2017

Aug 11, 2017

BUY
N/A
4,300
4,300 $741,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Hamel Associates, Inc. Portfolio

Follow Hamel Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamel Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hamel Associates, Inc. with notifications on news.